Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit

Prabhu Rajagopalan, Robert K. Pelz, Pamela A Lipsett, Sandra M. Swoboda, Michael G. Rinaldi, Craig Hendrix

Research output: Contribution to journalArticle

Abstract

Study Objective. To determine the population pharmacokinetic parameters of enterally administered fluconazole in patients in a surgical intensive care unit (SICU). Design. Population pharmacokinetics component of a prospective, randomized clinical study. Setting. The SICU at a university hospital. Patients. One hundred ten patients with an expected length of stay in the SICU of 3 or more days and a need for intubation, in whom at least one fluconazole plasma concentration-time measurement was available. Intervention. Patients received fluconazole as an 800-mg loading dose and as a 200- or 400-mg (depending on renal function) daily maintenance dose. Fluconazole suspension was administered enterally followed by a 30-ml free water flush. Measurements and Main Results. Plasma samples were collected, and population pharmacokinetic analysis was performed with NONMEM software; a one-compartment pharmacokinetic model was used. Fluconazole clearance was dependent on creatinine clearance, and volume of distribution was dependent on body weight and age. In patients with creatinine clearance values greater than 80 ml/minute, between 30 and 80 ml/minute, and less than 30 ml/minute, geometric mean (percentage coefficient of variation) fluconazole clearance was 14.39 ml/minute (21%), 10.53 ml/minute (28%), and 5.47 ml/minute (30%), respectively. The geometric mean (percentage coefficient of variation) volume of distribution in all patients was 1.27 L/kg (28%) and decreased with increasing age. Conclusions. Fluconazole clearance values in patients in the SICU who had normal renal function and in those with renal impairment were in agreement with previously reported data. Fluconazole volume of distribution was larger and half-life was longer in the SICU population than in healthy subjects.

Original languageEnglish (US)
Pages (from-to)592-602
Number of pages11
JournalPharmacotherapy
Volume23
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Fluconazole
Critical Care
Small Intestine
Intensive Care Units
Pharmacokinetics
Population
Kidney
Creatinine
Intubation
Half-Life
Length of Stay
Suspensions
Healthy Volunteers
Software
Body Weight
Water

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit. / Rajagopalan, Prabhu; Pelz, Robert K.; Lipsett, Pamela A; Swoboda, Sandra M.; Rinaldi, Michael G.; Hendrix, Craig.

In: Pharmacotherapy, Vol. 23, No. 5, 01.05.2003, p. 592-602.

Research output: Contribution to journalArticle

Rajagopalan, Prabhu ; Pelz, Robert K. ; Lipsett, Pamela A ; Swoboda, Sandra M. ; Rinaldi, Michael G. ; Hendrix, Craig. / Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit. In: Pharmacotherapy. 2003 ; Vol. 23, No. 5. pp. 592-602.
@article{44166a0034be4dadb6b7b82bb7c1f71e,
title = "Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit",
abstract = "Study Objective. To determine the population pharmacokinetic parameters of enterally administered fluconazole in patients in a surgical intensive care unit (SICU). Design. Population pharmacokinetics component of a prospective, randomized clinical study. Setting. The SICU at a university hospital. Patients. One hundred ten patients with an expected length of stay in the SICU of 3 or more days and a need for intubation, in whom at least one fluconazole plasma concentration-time measurement was available. Intervention. Patients received fluconazole as an 800-mg loading dose and as a 200- or 400-mg (depending on renal function) daily maintenance dose. Fluconazole suspension was administered enterally followed by a 30-ml free water flush. Measurements and Main Results. Plasma samples were collected, and population pharmacokinetic analysis was performed with NONMEM software; a one-compartment pharmacokinetic model was used. Fluconazole clearance was dependent on creatinine clearance, and volume of distribution was dependent on body weight and age. In patients with creatinine clearance values greater than 80 ml/minute, between 30 and 80 ml/minute, and less than 30 ml/minute, geometric mean (percentage coefficient of variation) fluconazole clearance was 14.39 ml/minute (21{\%}), 10.53 ml/minute (28{\%}), and 5.47 ml/minute (30{\%}), respectively. The geometric mean (percentage coefficient of variation) volume of distribution in all patients was 1.27 L/kg (28{\%}) and decreased with increasing age. Conclusions. Fluconazole clearance values in patients in the SICU who had normal renal function and in those with renal impairment were in agreement with previously reported data. Fluconazole volume of distribution was larger and half-life was longer in the SICU population than in healthy subjects.",
author = "Prabhu Rajagopalan and Pelz, {Robert K.} and Lipsett, {Pamela A} and Swoboda, {Sandra M.} and Rinaldi, {Michael G.} and Craig Hendrix",
year = "2003",
month = "5",
day = "1",
doi = "10.1592/phco.23.5.592.32202",
language = "English (US)",
volume = "23",
pages = "592--602",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit

AU - Rajagopalan, Prabhu

AU - Pelz, Robert K.

AU - Lipsett, Pamela A

AU - Swoboda, Sandra M.

AU - Rinaldi, Michael G.

AU - Hendrix, Craig

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Study Objective. To determine the population pharmacokinetic parameters of enterally administered fluconazole in patients in a surgical intensive care unit (SICU). Design. Population pharmacokinetics component of a prospective, randomized clinical study. Setting. The SICU at a university hospital. Patients. One hundred ten patients with an expected length of stay in the SICU of 3 or more days and a need for intubation, in whom at least one fluconazole plasma concentration-time measurement was available. Intervention. Patients received fluconazole as an 800-mg loading dose and as a 200- or 400-mg (depending on renal function) daily maintenance dose. Fluconazole suspension was administered enterally followed by a 30-ml free water flush. Measurements and Main Results. Plasma samples were collected, and population pharmacokinetic analysis was performed with NONMEM software; a one-compartment pharmacokinetic model was used. Fluconazole clearance was dependent on creatinine clearance, and volume of distribution was dependent on body weight and age. In patients with creatinine clearance values greater than 80 ml/minute, between 30 and 80 ml/minute, and less than 30 ml/minute, geometric mean (percentage coefficient of variation) fluconazole clearance was 14.39 ml/minute (21%), 10.53 ml/minute (28%), and 5.47 ml/minute (30%), respectively. The geometric mean (percentage coefficient of variation) volume of distribution in all patients was 1.27 L/kg (28%) and decreased with increasing age. Conclusions. Fluconazole clearance values in patients in the SICU who had normal renal function and in those with renal impairment were in agreement with previously reported data. Fluconazole volume of distribution was larger and half-life was longer in the SICU population than in healthy subjects.

AB - Study Objective. To determine the population pharmacokinetic parameters of enterally administered fluconazole in patients in a surgical intensive care unit (SICU). Design. Population pharmacokinetics component of a prospective, randomized clinical study. Setting. The SICU at a university hospital. Patients. One hundred ten patients with an expected length of stay in the SICU of 3 or more days and a need for intubation, in whom at least one fluconazole plasma concentration-time measurement was available. Intervention. Patients received fluconazole as an 800-mg loading dose and as a 200- or 400-mg (depending on renal function) daily maintenance dose. Fluconazole suspension was administered enterally followed by a 30-ml free water flush. Measurements and Main Results. Plasma samples were collected, and population pharmacokinetic analysis was performed with NONMEM software; a one-compartment pharmacokinetic model was used. Fluconazole clearance was dependent on creatinine clearance, and volume of distribution was dependent on body weight and age. In patients with creatinine clearance values greater than 80 ml/minute, between 30 and 80 ml/minute, and less than 30 ml/minute, geometric mean (percentage coefficient of variation) fluconazole clearance was 14.39 ml/minute (21%), 10.53 ml/minute (28%), and 5.47 ml/minute (30%), respectively. The geometric mean (percentage coefficient of variation) volume of distribution in all patients was 1.27 L/kg (28%) and decreased with increasing age. Conclusions. Fluconazole clearance values in patients in the SICU who had normal renal function and in those with renal impairment were in agreement with previously reported data. Fluconazole volume of distribution was larger and half-life was longer in the SICU population than in healthy subjects.

UR - http://www.scopus.com/inward/record.url?scp=0038031860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038031860&partnerID=8YFLogxK

U2 - 10.1592/phco.23.5.592.32202

DO - 10.1592/phco.23.5.592.32202

M3 - Article

C2 - 12741433

AN - SCOPUS:0038031860

VL - 23

SP - 592

EP - 602

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 5

ER -